ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials
Crossref DOI link: https://doi.org/10.1007/s00384-019-03430-y
Published Online: 2019-11-16
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdel-Rahman, Omar http://orcid.org/0000-0002-5117-2502
Text and Data Mining valid from 2019-11-16
Version of Record valid from 2019-11-16
Article History
Accepted: 10 October 2019
First Online: 16 November 2019